Extragastric manifestations of Helicobacter pylori infection

Minerva Medica

Volumn 97, Issue 1, 2006, Pages 39-45

  Franceschi, F ^a   Roccarina, D ^a   Gasbarrini, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Extragastric manifestations; Helicobacter pylory; Infections

Indexed keywords

ATHEROSCLEROSIS; CHRONIC URTICARIA; DISEASE ASSOCIATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATOBILIARY DISEASE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IN VITRO STUDY; IRON DEFICIENCY ANEMIA; ISCHEMIC HEART DISEASE; REVIEW; ROSACEA;

ANEMIA, IRON-DEFICIENCY; BILIARY TRACT DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MYOCARDIAL ISCHEMIA; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; ROSACEA;

EID: 33646351303     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Graham DY, Go MF. Helicobacter pylori: current status. Gastroenterology 1993;105:279-82.
2. Correa P, Fox J, Fontham E, Ruiz B, Lin YP, Zavala D et al. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990;66:2569-74.
3. Isaacson PG, Spencer J. Gastric lymphoma and Helicobacter pylori. Important Adv Oncol 1996; 111-21.
4. Carloni E, Cremonini F, Di Caro S, Padalino C, Gerardino L, Santoliquido A et al. Helicobacter pylori-related extradigestive diseases and effects of eradication therapy. Dig Liver Dis 2000;32 Suppl 3:8214-6.
5. Gasbarrini A, Franceschi F, Armuzzi A, Ojetti V, Candelli M, Torre ES et al. Extradigestive manifestations of Helicobacter pylori gastric infection. Gut 1999;45 Suppl 1:19-12.
6. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994;71:43-79.
7. Danesh J, Wong Y, Ward M, Muir J. Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease. Heart 1999;81:245-7.
8. Alkout AM, Ramsay EJ, Mackenzie DA, Weir DM, Bentley AJ, Elton RA et al. Quantitative assessment of IgG antibodies of Helicobacter pylori and outcome of ischaemic heart disease. FEMS Immunol Med Microbiol 2002;29:271-4.
9. Pellicano R, Mazzarello MG, Morelloni S, Allegri M, Arena V, Ferrari M et al. Acute myocardial infarction and Helicobacter pylori seropositivity. Int J Clin Lab Res 1999;29:141-4.
10. Danesh J, Youngman L, Clark S, Parish S, Peto R, Collins R. Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study. BMJ 1999;319:1157-62.
11. Gorunovsiaia IG. Features of ulcer disease in elderly patients with ischaemic heart disease. Eksp Klin Gastroenterol 2002;117:16-21.
12. Yamaoka Y, El-Zimaity HM, Gutierrez O, Figura N, Kim JG, Kodama T et al. Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology 1999;117:342-9.
13. Gunn M, Stephens JC, Thompson JR, Rathbone BJ, Samani NJ. Significant association of Cag-A positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart 2000;84:267-271.
14. Gasbarrini A, Franceschi F, Armuzzi A, Ojetti V, Candelli M, Torre ES et al. Extradigestive manifestations of Helicobacter pylori gastric infection. Gut 1999;45 Suppl 1:19-112
15. Gasbarrini A, Serricchio M, Tondi P, Franceschi F, Ojetti V, Sanz Torre E et al. Helicobacter pylori infection and vascular diseases. Ital J Gastroenterol Hepatol 1998;30 Suppl 3:5307-9.
16. Kowalski M, Konturek PC, Pieniazek P, Karczewska E, Kluczka A, Grove R et al. Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. Dig Liver Dis 2001;33:222-9.
17. Pasceri V, Cammarota G, Patti G, Cuoco L, Gasbarrini A, Grillo RL et al. Association of virulent Helicobacter pylori strains with ischaemic heart disease. Circulation 1998;97:1675-9.
18. Singh RK, McMahon AD, Patel H, Packard CJ, Rathbone BJ, Samani NJ. Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease. Heart 2002;88:43-6.
19. Pietroiusti A, Diomedi M, Silvestrini M, Cupini LM, Luzzi I, Gomez-Miguel MJ et al. Cytotoxin associated gene-A-positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation 2002;106:580-4.
20. Majka J, Rog T, Konturek PC, Konturek SJ, Bielanski W, Kowalsky M et al. Influence of chronic Helicobacter pylori infection on ischaemic cerebral stroke risk factors. Med Sci Monit 2002;8:CR675-84.
21. Gabrielli M, Santoliquido A, Cremonini F, Cicconi V, Candelli M, Serricchio M et al. CagA-positive cytotoxic H. pylori strains as a link between plaque instability and atherosclerotic stroke. Eur Heart J 2004;25:64-8.
22. Zito F, Di Castelnuovo A, D'Orazio A, Negrini R, De Lucia D, Donati MB et al. Helicobacter pylori infection and the risk of myocardial infarction: role of fibrinogen and its genetic control. Thromb Haemost 1999;82:14-8.
23. Hoffmeister A, Rothenbacher D, Bode G, Persson K, Marz W, Nauck MA et al. Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arterioscler Thromb Vasc Biol 2001;21:427-32.
24. Schumacher A, Seljeflot I, Lerkerod AB, Sommervoll L, Otterstad JE, Arnesen H. Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease. Atherosclerosis 2002;164:153-60.
25. Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 2001;32:385-91.
26. Kowalski M, Rees W, Konturek PC, Grove R, Scheffold T, Meixner H et al. Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina. Dig Liver Dis 2002;34:398-402.
27. Kowalski M. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. J Physiol Pharmacol 2001;52 Suppl 1:3-31.
28. Schumacher A, Seljeflot I, Lerkerod AB, Sommervoll L, Otterstad JE, Arnesen H. Does infection with Chlamydia pneumoniae and/or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans? Clin Microbiol Infect 2002;8:654-61.
29. Xu Q, Schett G, Perschinka H, Mayr M, Egger G, Oberhollenzer F et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 2000;102:14-20.
30. Birnie DH, Holme ER, McKay IC, Hood S, McColl KE, Hillis WS. Association between antibodies to heat schock protein 65 and coronary atherosclerosis. Possible mechanism of action of "Helicobacter pylori" and other bacterial infections in increasing cardiovascular risk. Eur Heart J 1998;19:387-94.
31. Roivainen M, Viik-Kajander M, Palosuo T, Toivanen P, Leinonen M, Saikku P et al. Infections, inflammation, and the risk of coronary heart disease. Circulation 2000;101:252-7.
32. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis 1999;142: 207-10.
33. Bielanski W. Epidemiological study on Helicobacter pylori infection and extragastroduodenal disorders in Polish population. J Physiol Pharmacol 1999;50:723-33.
34. Quinn MJ, Foley JB, Mulvihill NT, Lee J, Crean PA, Walsh MJ et al. Helicobacter pylori serology in patients with angiographically documented coronary artery disease. Am J Cardiol 1999;83:1664-6.
35. Tasi CJ, Huang TY. Relation of Helicobacter pylori infection and angiographically demonstrated coronary artery disease. Dig Dis Sci 2000;45:1227-32.
36. Pieniazek P, Karczewska E, Duda A, Tracz W, Pasowicz M, Konturek SJ. Association of Helicobacter pylori infection with coronary heart disease. J Physiol Pharmacol 1999;50:743-51.
37. Carlsson J, Miketic S, Brom J, Ross R, Bachmann H, Tebbe U. Prior cytomegalovirus, Chlamydia pneumoniae or Helicobacter pylori infection and the risk of restenosis after percutaneous transluminal coronary angioplasty. Int J Cardiol 2000;73:165-71.
38. Schiele F, Batur MK, Seronde MF, Meneveau N, Sewoke P, Bassignot A et al. Cytomegalovirus, Chlamydia pneumoniae and Helicobacter pylori IgG antibodies and restenosis after stents implantation: an angiographic and intravascular ultrasound study. Heart 2001;85:304-11.
39. Danesh J, Koreth J, Youngman L, Collins R, Arnold JR, Balarajan Y et al. Is Helicobacter pylori a factor in coronary atherosclerosis? J Clin Microbiol 1999;37:1651.
40. Murray LJ, Bamford KB, Kee F, McMaster D, Cambien F, Dallongeville J et al. Infection with virulent strains of Helicobacter pylori is not associated with ischaemic heart disease: evidence from a population-based case-control study of myocardial infarction. Atherosclerosis 2000;149:379-85.
41. Franceschi F, Sepulveda AR, Gasbarrini A, Pola P, Silveri NG, Gasbarrini G et al. Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation 2002;106:430-4.
42. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. Biomed J 1998;346:1130-2.
43. Schweeger I, Fitscha P, Sinzinger H. Successful eradication of Helicobacter pylori as determined by 13C-urea breath test does not alter fibrinogen and acute phase response markers. Thromb Res 2000;97:411-20.
44. Yusuf SW, Mishra RM. Effect of Helicobacter pylori infection on fibrinogen level in elderly patients with ischaemic heart disease. Acta Cardiol 2002;57:317-22.
45. Parente F, Imbesi V, Cucino C, Maconi G, Russo U, Duca PG et al. Helicobacter pylori CagA seropositivity does not influence inflammatory parameters, lipid concentrations and haemostatic factors in healthy individuals. J Intern Med 2000;247:213-7.
46. Rothenbacher D, Hoffmeister A, Bode G, Miller M, Koenig W, Brenner H. Helicobacter pylori heat shock protein 60 and risk of coronary heart disease: a case control study with focus on markers of systemic inflammation and lipids. Atherosclerosis 2001;156:193-9.
47. Fukuda K, Kuroki T, Tajima Y, Tsuneoka N, Kitajima T, Matsuzaki S et al. Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis 2002;23:1927-31.
48. Kuroki T, Fukuda K, Yamanouchi K, Kitajima T, Matsuzaki S, Tajima Y et al. Helicobacter pylori accelerates the biliary epithelial cell proliferation activity in hepatolithiasis. Hepatogastroenterology 2002;49:648-51.
49. Bulajic M, Maisonneuve P, Schneider-Brachert W, Muller P, Reischl U, Stimec B et al. Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer 2002;95:1946-53.
50. Fallone CA, Chiba N, Buchan A. Two decades of Helicobacter pylori: a review of the Fourth Western Pacific Helicobacter Congress. Can J Gastroenterol 2002;16:559-63.
51. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998;352:878.
52. Hino M, Yamane T, Park K, Takubo T, Ohta K, Kitagawa S et al. Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura. Ann Hematol 2003;82:30-2.
53. Kohda K, Kuga T, Kogawa K, Kanisawa Y, Koike K, Kuroiwa G et al. Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br J Haematol 2002;118:584-8.
54. Veneri D, Franchini M, Gottardi M, D'Adda M, Ambrosetti A, Krampera M et al. Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura. Haematologica 2002;87:1177-9.
55. Huber MR, Kumar S, Tefferi A. Treatment advances in adult immune thrombocytopenic purpura. Ann Hematol 2003;82:723-37.
56. Franceschi F, Christodoulides N, Kroll MH, Genta RM. Helicobacter pylori and idiopathic thrombocytopenic purpura. Ann Intern Med 2004;140:766-7.
57. Fukuda S, Shimoyama T, Umegaki N, Mikami T, Nakano H, Munakata A. Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria. J Gastroenterol 2004;39:827-30.
58. Annibale B, Capurso G, Lahner E, Passi S, Ricci R, Maggio F et al. Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut 2003;52:496-501.
59. Seo JK, Ko JS, Choi KD. Serum ferritin and Helicobacter pylori infection in children: a sero-epidemiologic study in Korea. J Gastroenterol Hepatol 2002;17:754-7.
60. Sugiyama T, Tsuchida M, Yokota K. Improvement of long-standing iron-deficiency anemia in adults after eradication of Helicobacter pylori infection. Intern Med 2002;41:491-4.
61. Choe YH, Kim SK, Hong YC. The relationship between Helicobacter pylori infection and iron deficiency: seroprevalence study in 937 pubescent children. Arch Dis Child 2003;88:178.
62. Kostaki M, Fessatou S, Karpathios T. Refractory iron-deficiency anaemia due to silent Helicobacter pylori gastritis in children. Eur J Pediatr 2003;162:177-9.
63. Malik AA, Ganti AK, Potti A, Levitt R, Hanley JF. Role of Helicobacter pylori infection in the incidence and clinical course of monoclonal gammopathy of undetermined significance. Am J Gastroenterol 2002;97:1371-4.
64. Rajkumar SV, Kyle RA, Plevak MF, Murray JA, Therneau TM. Helicobacter pylori infection and monoclonal gammopathy of undetermined significance. Br J Haematol 2002;119:706-8.
65. Di Campli C, Gasbarrini A, Nucera E, Franceschi F, Ojetti V, Sanz Torre E et al. Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci 1998;43:1226-9.
66. Gasbarrini A, Franceschi F. Does H. Pylori infection play a role in idiopathic thrombocytopenic purpura and in other autoimmune diseases? Am J Gastroenterol 2005;100:1271-3.
67. Szlachcic A. The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol 2002;16:328-33.
68. Kazerooni T, Taallom M, Ghaderi AA. Helicobacter pylori seropositivity in patients with hyperemesis gravidarum. Int J Gynaecol Obstet 2002;79:217-20.
69. Salimi-Khayati A, Sharami H, Mansour-Ghanaei F, Sadri S. Fallah MS. Helicobacter pylori aeropositivity and the incidence of hyperemesis gravidarum. Med Sci Monk 2003;9:CR12-5.
70. Bagis T, Gumurdulu Y, Kayaselcuk F, Yilmaz ES, Killicadag E, Tarim E. Endoscopy in hyperemesis gravidarum and Helicobacter pylori infection. Int J Gynaecol Obstet 2002;79:105-9.
71. Eslick GD, Yan P, Xia HH, Murray H, Spurrett B, Talley NJ. Foetal intrauterine growth restrictions with Helicobacter pylori infection. Aliment Pharmacol Ther 2002;16:1677-82.
72. Ertem D, Pehlivanoglu E. Helicobacter pylori may influence height in children independent of socioeconomic factors. J Pediatr Gastroenterol Nutr 2002;35:232-3.
73. Takahashi M, Kimura H, Watanabe K. Helicobacter pylori infection in patients with idiopathic short stature. Pediatr Int 2002;44:277-80.
74. Passaro DJ, Taylor DN, Gilman RH, Cabrera L, Parsonnet J. Growth slowing after acute Helicobacter pylori infection is age-dependent. J Pediatr Gastroenterol Nutr 2002;35:522-6.
75. Furuta T, Shirai N, Xiao F, Takashima M, Hanai H. Effect of Helicobacter pylori infection and its eradication on nutrition. Aliment Pharmacol Ther 2002;16:799-806.
76. Figura N, Piomboni P, Ponzetto A, Gambera L, Lenzi C, Vaira D et al. Helicobacter pylori infection and infertility. Eur J Gastroenterol Hepatol 2002;14:663-9.
77. Zentilin P, Seriolo B, Dulbecco P. Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis. Aliment Pharmacol Ther 2002;16:1291-9.